Page last updated: 2024-09-02

fingolimod hydrochloride and Optic Nerve Diseases

fingolimod hydrochloride has been researched along with Optic Nerve Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abouzeid, N; Al-Jumah, M; Alroughani, R; Alsaadi, T; Alsharoqi, I; Bohlega, S; Dahdaleh, M; ElKallab, K; Hashem, S; Inshasi, J; Khoury, S; Tawfeek, T; Yamout, B; Zakaria, M1

Other Studies

1 other study(ies) available for fingolimod hydrochloride and Optic Nerve Diseases

ArticleYear
Consensus guidelines for the diagnosis and treatment of multiple sclerosis.
    Current medical research and opinion, 2013, Volume: 29, Issue:6

    Topics: Antibodies, Monoclonal, Humanized; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Middle East; Multiple Sclerosis; Myelitis; Natalizumab; Optic Nerve Diseases; Optic Neuritis; Propylene Glycols; Sphingosine; Spinal Cord Diseases

2013